Dean C.Bachus

Partner

Chicago + 1.312.269.4220

For more than a decade, Dean Bachus has focused his practice on executive compensation, benefits, and ERISA transactional matters. His experience covers tax planning and structuring compensation and benefit arrangements in domestic and international business acquisitions and dispositions. He also advises clients in connection with all compensation and employee benefit-related aspects of corporate transactions, reorganizations, financing arrangements, and public offerings, including negotiating, reviewing, and drafting transactional documents, supervising due diligence, and identifying issues arising under, and assisting in complying with, the Internal Revenue Code, ERISA, applicable labor laws, federal securities laws, and applicable exchange regulations.

Dean's practice includes designing, negotiating, and drafting equity-based compensation plans (including stock option, restricted stock, and phantom equity arrangements); cash bonus plans; employment, consulting, termination, severance, and change-in-control contracts; and restrictive covenant agreements, including noncompetition, nonsolicitation, and confidentiality arrangements.

Dean also advises clients on the structure, implementation, and administration of nonqualified employee compensation plans, programs, and arrangements, including the associated ERISA, federal tax, and securities implications. He also provides counsel to management teams and boards of directors on executive compensation and change-in-control arrangements in connection with corporate transactions and reorganizations and consults with shareholders, senior executives, and boards of directors on transactional strategies.

Dean has represented major private equity funds and publicly traded companies in hundreds of acquisitions and dispositions, focusing on benefit and compensation issues that arise in such transactions, as well as the design and maintenance of incentive programs and facilitating management turnover.

Experience

  • Applus Technologies sold to Opus InspectionJones Day advised Applus Servicios Tecnologicos, S.L.U. in the sale of one of its U.S. subsidiaries, Applus Technologies Inc., to Opus Inspection, Inc.
  • Riverside acquires ProVelocity and IronEdgeJones Day represented The Riverside Company in the acquisition of ProVelocity, a long-standing managed IT solutions provider that helps businesses and government agencies manage their technology needs, and IronEdge, a leading IT solutions provider for Texas-based businesses.
  • Accelmed Partners leads $30 million private placement of Common Stock issued by Minerva Surgical, Inc.Jones Day represented Accelmed Partners in connection with its purchase of $30 million of Common Stock in a private placement issued by Minerva Surgical, Inc., granting Accelmed Partners a controlling stake in Minerva Surgical.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • Hard Rock International acquires The Mirage Las Vegas Hotel and CasinoJones Day represented Hard Rock International (Hard Rock) on the acquisition of The Mirage Las Vegas Hotel and Casino in Las Vegas from MGM Resorts International.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Alternative investment management firm acquires leading provider of static and electronic outdoor advertising in Commonwealth of Puerto RicoJones Day advised an alternative investment management firm in the acquisition and senior debt financing of a leading provider of static and electronic outdoor advertising in the Commonwealth of Puerto Rico.
  • Accelmed Partners makes $35 million investment in SKNV Inc.Jones Day advised Accelmed Partners in its $35 million investment in SKNV Inc., a full continuum-of-care dermatology digital health company for in-practice dispensing and ecommerce of customized prescriptions and skincare.
  • CDPQ leads $125 million Series D financing of Soli OrganicJones Day advised CDPQ as lead investor in the $125 million Series D financing of Soli Organic, the nation's only soil-based, indoor farming company delivering 100% USDA certified organic produce.
  • Henderson Park acquires D.C. Mandarin OrientalJones Day represented Henderson Park Capital Partners in its joint venture with Salamander Hospitality, LLC and the joint venture's $139 million acquisition and financing of the D.C. Mandarin Oriental, a 373-room luxury hotel located in the Southwest waterfront area of Washington D.C. 
  • NerdWallet acquires On The Barrelhead for $120 millionJones Day advised NerdWallet, Inc. (Nasdaq: NRDS), a platform that provides financial guidance to consumers and small- and mid-sized businesses, in its acquisition of On the Barrelhead, Inc. for total consideration of $120 million, consisting of approximately $70 million in cash and $50 million in NerdWallet Class A common stock.
  • Plastic Omnium acquires ams OSRAM Automotive Lighting Systems from ams OSRAM GroupJones Day advised Plastic Omnium in the acquisition of the Automotive Lighting Systems (AMLS) business of ams OSRAM Group in a highly complex international carve-out transaction.
  • Selman & Company, LLC sold to One80 IntermediariesJones Day advised Selman & Company, LLC (SelmanCo) in connection with the sale of SelmanCo to One80 Intermediaries, Inc.
  • Ansys, Inc. acquires OnScale, Inc.Jones Day advised Ansys, Inc. in the acquisition of OnScale, Inc., a cloud simulation provider.
  • Aaron's Company acquires BrandsMart U.S.A. for $230 millionJones Day advised The Aaron's Company, Inc., a leading technology-enabled, omnichannel provider of lease-to-own and purchase solutions, on its acquisition of BrandsMart U.S.A. for $230 million.
  • Morgan Stanley Capital Partners portfolio company acquires Labeltronix, LLCJones Day advised Morgan Stanley Capital Partners in connection with the acquisition by portfolio company AWT Labels & Packaging, Inc. (AWT) of Labeltronix, LLC, a leading label manufacturer of premium craft labels serving some of the country's most prominent brands, in a variety of markets including wine and spirits, craft beer, nutraceutical, food and beverage, and other CPG sectors.
  • City of Hope acquires Cancer Treatment Centers of AmericaJones Day advised City of Hope, a world-renowned, National Cancer Institute (NCI)-designated comprehensive cancer research and treatment organization, in connection with its acquisition of Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers across the United States.
  • Baird Capital sells portfolio company Vitalyst to Alithya Group, Inc.Jones Day represented Baird Capital in connection with the sale of its portfolio company Vitalyst, LLC to Alithya Group, Inc.
  • ABB acquires controlling interest in InCharge EnergyJones Day advised ABB Ltd. in the acquisition of a controlling interest in InCharge Energy from existing shareholders.
  • GoEngineer completes recapitalization with Court Square Capital PartnersJones Day advised GoEngineer, a leading provider of 3D design and additive manufacturing solution, in connection with its recapitalization with Court Square Capital Partners.